期刊文献+

脑钠肽与急性冠状动脉综合征关系的研究 被引量:6

The research of the relationship between the plasma brain natriuretic peptide and acute coronary syndromes
暂未订购
导出
摘要 目的探讨脑钠肽(BNP)与急性冠状动脉综合征(ACS)的关系。方法将115例入院患者行冠状动脉造影后分为4组:稳定型心绞痛组(SAP)24例,不稳定型心绞痛组(UAP)35例,急性心肌梗死组(AMI)28例,冠状动脉造影无狭窄或狭窄〈25%者为对照组28例。测定其外周静脉血脑钠肽(BNP)水平和超敏C反应蛋白(hs—CRP)水平,分析各组BNP水平之间的关系,以及Gensim积分和hs—CRP水平与其相应的BNP水平的关系。结果①UAP组、AMI组血浆BNP浓度较对照组、SAP组明显升高[(82.78±14.15)μg/L、(91.87±17.00)μg/L比(41.93±6.34)Dg/L、(45.52±6.65)μg/L],且差异有统计学意义(P〈0.05);SAP组血浆BNP浓度较对照组升高[(45.52±6.65)μg/L比(41.93±6.34)μg/L],但差异无统计学意义(P〉0.05);AMI组血浆BNP浓度较UAP组升高[(91.87±17.00)μg/L比(82.78±14.15)μg/L],但差异无统计学意义(P〉0.05)。②血浆BNP浓度与其相应的Gensim积分呈明显正相关(r=0.331,P〈0.05)。③血浆BNP浓度与其相应的hs—CRP水平呈明显正相关(r=0.475,P〈0.05)。结论血浆BNP浓度可能作为预测急性冠脉综合征危险分层和判断预后的参考指标之一。 Objective To explore the relationship between the plasma concentration of brain natriuretie peptide (BNP) and acute coronary syndromes (ACS). Methods 115 patient who underwent coronary angiography were included in the study and divided into four groups according to extent of coronary artery stenosis: 24 patients with SAP, 35 patients with UAP, 28 patients with AMI and 28 control subjects. The concentration of BNP and hs-CRP in all subjects were measured.Tbe relationship between the concentration of BNP and Gensini score was analyzed.And the relationship between concentration of BNP and hs-CRP was analyzed. Results (1)The concen- tration of BNP in UAP and AMI group was significantly higher than that in control and SAP group [ (82.78± 14.15)μg/L, (91.87±17.00)μg/L vs (41.93±6.34)μg/L, (45.52±6.65)μg/L,P〈0.05 ], there was no statistical difference between the concentration of BNP in SAP and control group[ (45.52±6.65)μg/L vs (41.93±6.34)μg/L, P〉0.05 ], and there was no statistical difference among the concentration of BNP in UAP and AMI group [ (82.78± 14.15)p.g/L vs (91.87±17.00)μg/L, P〉0.05). (2)The concentration of BNP was correlated with Gemini score(r= 0.331 ,P〈0.05 ). (3)The concentration of BNP was correlated with the concentration of hs-CRP(r=0.475, P〈0.05 ). Conclusion BNP may be the predictor of ACS and the degree of coronary artery stenosis.
出处 《中国心血管病研究》 CAS 2010年第8期568-570,共3页 Chinese Journal of Cardiovascular Research
关键词 急性冠状动脉综合征 脑钠肽 超敏C反应蛋白 冠状动脉造影 Acute coronary syndrome Brain natn'uretic peptide hs-CRP Coronary angiography
  • 相关文献

参考文献12

  • 1杨水祥,胡大一.不稳定型心绞痛和非ST段抬高性心肌梗死治疗的有关策略问题[J].中国心血管病研究,2003,1(2):91-93. 被引量:6
  • 2Yasue H,Yoshimura M,Sumida H,et al.Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natrinretic peptide in normaol subjects and patients with heart failure.Circulation,1994,90:195-203.
  • 3Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease.Am J Cardiol,1983,51:606.
  • 4Suzuki T,Yamazaki T,Yazaki Y.The role of the natriuretic peptide in the cardiovascular system.Cardiovasc Res,2001,51:489-494.
  • 5Morita E,Yesue H,Yoshimura M,et al.Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infraction.Circulation,1993,88:82-91.
  • 6Arakawa N,Nakamura M,Aoki H,et al.Relationship between plasma level of and myocardial infract size.Cardiology,1994,85:334-340.
  • 7de Lemos JA,Morrow DA.Brain natriuretic peptide measurement in acute coronary syndromes:ready for clinical application.Circulation,2002,106:2868.
  • 8Ross R.Atherosclerosis-an inflammatory disease.N Engl J Med,1999,340:115-126.
  • 9钱文浩.冠心病患者血清白介素-8、C-反应蛋白变化及其意义[J].中国心血管病研究,2005,3(1):37-38. 被引量:5
  • 10王付彬.C-反应蛋白水平与急性心肌梗死预后的关系[J].中国心血管病研究,2005,3(4):294-295. 被引量:13

二级参考文献26

  • 1[1]Cannon CP, Trupie AGG. Unstable angina and NonST - Elevation myocardial infarction, initial antithrombotic therapy and early invasive strategy[ J ]. Circulation, 2003,107: 2640 - 2645
  • 2[2]Antman EM, Cohen M, Bemink PH, et al. The TIMI risk score for unstable angina/non- ST elevation MI:a method for prognostication and therapeutic decision making[J]. JAMA, 2000, 284: 835 - 842
  • 3[3]Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac- specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes[J]. N Engl J Med, 1996, 335:1342- 1349
  • 4[4]Cannon CP, Weintraub WS, Demopoulos LA, et al.Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Ⅱ b/ Ⅲ a inhibitor tirofiban[J]. N Engl J Med, 2001,344:1879 - 1887
  • 5[5]Lindahl B, Toss H, Siegbahn A, et al. Fragmin during instability in coronary artery disease: markers of myocardial damage and inflammation in relation to longterm mortality in unstable coronary artery disease[J].N Engl J Med, 2000, 343:1139 - 1147
  • 6[6]de Lemos JA, Morrow DA, Bentley JH, et al.The prognostic value of B - type natriuretic peptide in patients with acute coronary syndromes[ J ]. N Engl J Med,2001,345:1014 - 1021
  • 7[7]Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non- ST elevation acute coronary syndromes: simultaneous assessment of troponin I. C - reactive protein, and B - type natriuretic peptide[ J ]. Circulation, 2002, 105:1760 -1763
  • 8[8]Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non - ST segment elevation myocardial infarction - 2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Committee on the Management of Unstable Angina)[J]. Circulation, 2002,106:1893 - 1900
  • 9[9]The GUSTO Ⅳ - ACS Investigators. Effect of glycoprotein Ⅱ b/Ⅲ a receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: the GUSTO- Ⅳ- ACS randomized trial[J]. Lancet, 2001,357:1915 -1924
  • 10[10]Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atrovastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial[J ]. JAMA, 2001, 285:1711 -1718

共引文献20

同被引文献72

  • 1王琳,熊为国,郭晓宁,陈新.脑利钠肽的生理特性及其重组脑利钠肽在急性心力衰竭治疗中的应用[J].中华心律失常学杂志,2006,10(1):77-78. 被引量:16
  • 2Vanderheyden M, Vrints C, Verstreken S, et al. B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications. Biomark Meal,2010,4: 315 -320.
  • 3Magnusson M, Jovinge S, Shahgaldi K. Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients. Cardiovasc diabetol, 2010,9 : 2.
  • 4De Lemos JA, Hildebrandt P. Amino-terminal pro-B-type natri- uretie peptides:testing in general populations. Am J Cardiol, 2008,101 : 16-20.
  • 5Winkler K, Wanner C, Drechsler C, et al. Change in N-termi- nal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients. Eur Heart J, 2008,29 : 2092-2099.
  • 6Rivera M, Cortes R, Portoles M, et al. Plasma concentration of big endothelin-I and its relation with plasma NT-proBNP and ventricular function in heart failure patients. Rev Esp Cardiol, 2005,58 : 278-284.
  • 7Masson S, Latini R, Anand IS, et al. The prognostic value of big endothelin-1 in more than 2300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HEFT). J Card Fail,2006,12:375-380.
  • 8Pacher R, Stanke B, Hulsmann M, et al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coil Cardiol, 1996,27 : 633-641.
  • 9Watts S, Thakali K, Smark C, et al. Big ET-1 processing into vasoactive peptides in arteries and veins. Vascular Pharmacol, 2007,47 : 835-838.
  • 10Dencker M, Stagmo M, Dorkhan M. Relationship between natfi- uret-ie peptides and eehocardiography parameters in patientswith poorlyregulated type 2 diabetes. Vase Health Risk Manag, 2010,6 : 373-382.

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部